No.
if you buy EYMOC at for example 0.017 you then need to convert those into shares by paying the exercise price of 0.02. Making your total outlay 0.037.
The plus with options is the leverage. You get exposure to the company at a much reduced price compared to heads. But they expire at some point...in this case April 2020 so the time premium on the options should be much higher than it is at the moment.
EYMOC is a bargain at these levels IMO
No. if you buy EYMOC at for example 0.017 you then need to...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
